Bailard, Inc. Precision Biosciences Inc Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$4.65 - $8.73 $47,430 - $89,046	-10,200 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$4.66 - $8.7 $1.06 Million - $1.99 Million	-228,300 Reduced 95.72%	10,200 $85,000
Q1 2020 Apr 16, 2020	BUY	$5.05 - $15.01 $479,750 - $1.43 Million	95,000 Added 66.2%	238,500 $1.44 Million
Q4 2019 Jan 31, 2020	BUY	$6.32 - $19.66 $906,920 - $2.82 Million	143,500 New	143,500 $1.99 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $553M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.